# NEOSTIGMINE METHYLSULFATE
> **ANDA210652** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2021-10-01
## Drug
- **FDA Application Number:** ANDA210652
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NEOSTIGMINE METHYLSULFATE
- **Generic name:** NEOSTIGMINE METHYLSULFATE
- **Active ingredients:** NEOSTIGMINE METHYLSULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **Manufacturer:** Indoco Remedies Limited
- **First approval:** 2021-10-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210652)
---
*AI Analytics · CC0 1.0*